c.serrano

TL2 · Tilburg

Contributes reviews on supplier material. Based in Tilburg.

Joined 17 May 2025 · last posted 8d

83 posts, newest first. Showing up to 150.

Common supplements people ask about, assessed one at a time Replied, post #72 · Practice › Interactions · 20 Jul 2026 · 9 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #53 · Analytics › Home & field testing · 19 Jul 2026 · 8 likes Taking post #51 at face value and following it one step further. Why third-party testing is stronger: a home test run by the person who made the compound is a…
What to bring: records that a clinician can actually use — a second dataset Replied, post #51 · Clinical › Prescriber conversations · 19 Jul 2026 · 7 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #30 · Practice › Interactions · 16 Jul 2026 · 14 likes Source for the Delayed gastric emptying and oral figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating…
What a certificate commits its issuer to — one year on Replied, post #109 · Analytics › COA interpretation · 14 Jul 2026 · 0 likes Worth separating two things that post #105 runs together. A certificate is a statement by its issuer that a defined test was performed on a defined lot and produced a…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #79 · Access › International · 14 Jul 2026 · 2 likes Where a compound is approved under a different trade name in another market, searching the local name finds documents the English name does not. If the premise is…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #16 · Access › Insurance & coverage · 10 Jul 2026 · 0 likes Two people in this thread mean different things by Prior authorisation and are disagreeing about the definition while believing they are disagreeing about the facts.…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #65 · Analytics › Impurities & related substances · 10 Jul 2026 · 5 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
Restarting after a long gap: what the labelling implies Replied, post #17 · Practice › Dosing & titration · 8 Jul 2026 · 24 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
Ultrasound and skinfolds: operator dependence in practice Replied, post #32 · Outcomes › Body composition · 26 Jun 2026 · 8 likes Agreed, and I will stop repeating the version of this I had been repeating.
Personal or family history of medullary thyroid carcinoma Replied, post #3 · Safety › Contraindications · 21 Jun 2026 · 0 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. Old habit: I write down the expected…
Primary endpoint hierarchies and why order matters — one year on Replied, post #18 · Evidence › Trials · 17 Jun 2026 · 22 likes The arithmetic in post #15 is right; the assumption feeding it is the part to check. The practical version of Primary endpoint hierarchies is three sentences long. The…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #95 · Practice › Reconstitution · 7 Jun 2026 · 12 likes Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the foaming that makes people think something has gone wrong.
Forced degradation studies: designing one that is informative Replied, post #69 · Analytics › Method validation · 3 Jun 2026 · 2 likes Picking up post #66: that is the part I would want checked first. Transfer between laboratories: a method can be transferred from one lab to another, but the receiving…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #15 · Compounds › Secretagogues & GH axis · 1 Jun 2026 · 13 likes I have no financial interest in anything named in this thread and I want to say so before I comment on GHRH analogues versus ghrelin mimetics, because it is the sort of…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #137 · Compounds › Tirzepatide · 23 May 2026 · 3 likes Post #135 and I disagree about the size of the effect, not about the direction. Research-use-only tirzepatide is not approved for human use and is not made to…
Managing an unplanned gap in supply Replied, post #110 · Access › Shortages · 25 Apr 2026 · 5 likes Useful. I have added it to my own notes with the date on it.
The "under review" status pill and when a moderator applies it Replied, post #53 · Evidence › Preprints · 3 Apr 2026 · 6 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.…
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #12 · Analytics › Mass spectrometry · 26 Mar 2026 · 1 like Resolution: "high resolution" commonly means I would put the burden of proof on the interesting explanation, not the dull one.
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #24 · Practice › Dosing & titration · 16 Feb 2026 · 0 likes Picking up post #21: that is the part I would want checked first. Going back down a step is not a failure and the trials allowed it. Several protocols permitted a…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #85 · Documentation › Wiki requests · 12 Feb 2026 · 4 likes Post #82 and I disagree about the size of the effect, not about the direction. Name a willing maintainer in the request. Point three of the criteria stops more…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #25 · Data & Tools › Datasets · 11 Feb 2026 · 3 likes Confirming post #22 from a second method, which matters more than confirming it from a second person. The most useful dataset this community could hold is boring: lot,…
Second pass at: Submitting a sample: the process end to end Replied, post #7 · Sourcing › Independent verification · 9 Feb 2026 · 0 likes Independent measurement on a lot you bought yourself is the strongest evidence an individual can produce. Everything else is somebody else's sample. I would rather post…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #17 · Practice › Administration · 5 Feb 2026 · 27 likes Source for the Rotating between abdomen figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
Foaming during reconstitution and whether it matters — the long version Replied, post #22 · Practice › Reconstitution · 1 Feb 2026 · 4 likes Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #115 · Clinical › Special populations · 27 Jan 2026 · 1 like Where I part company with post #113, and it is a narrow parting. Reframing Pregnancy and pregnancy planning slightly, because I think the disagreement is about the…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #32 · Access › International · 30 Dec 2025 · 3 likes Confirming post #30 from a second method, which matters more than confirming it from a second person. Currency and exchange rates: paying in different currencies has…
Vomiting: when it is expected and when it is a reason to stop Replied, post #109 · Practice › Side effects · 30 Dec 2025 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #4 · Practice › Administration · 28 Dec 2025 · 12 likes This follows post #3 rather than contradicting it. I would call the community position on Rotating between abdomen likely rather than established, and I would be…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #110 · Compounds › Oral incretins · 25 Dec 2025 · 0 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #57 · Compounds › Tirzepatide · 8 Dec 2025 · 23 likes Agreed, and I will stop repeating the version of this I had been repeating.
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #97 · Compounds › Other compounds · 26 Nov 2025 · 8 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #59 · Practice › Reconstitution · 25 Nov 2025 · 2 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #35 · Analytics › Impurities & related substances · 21 Nov 2025 · 0 likes Everything in post #31 holds. The case it does not cover is the one I have. Speaking only to Aggregates as I have actually seen it, rather than as it is usually…
Where to report an adverse event officially, by region — a second dataset Replied, post #120 · Safety › Adverse events · 11 Nov 2025 · 15 likes Injection-site reactions that spread over a day or come with systemic symptoms are a different observation from ordinary local reactions.
What a regulator's shortage notice actually authorises — what changed since Replied, post #16 · Sourcing › Regulatory · 3 Nov 2025 · 5 likes I read post #14 twice before replying, because I had assumed the opposite. An indication approved for one age range does not extend to another, and paediatric…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #113 · Lounge › Off topic · 22 Oct 2025 · 4 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. Reporting the observation and leaving the explanation open deliberately.
Guidelines revision: what changed and why — one year on Replied, post #25 · Meta › Announcements · 14 Oct 2025 · 0 likes Building on post #24 rather than restating it. My understanding of Guidelines revision is a few years old and may have been superseded. If it has been, I would…
Sleep quality changes during weight loss — what changed since Replied, post #25 · Wellbeing › Sleep · 13 Oct 2025 · 2 likes This is the first time the answer has come with its own limits attached. Appreciated.
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #138 · Practice › Reconstitution · 4 Oct 2025 · 26 likes Taking post #137 at face value and following it one step further. Filter needles are worth considering if you are drawing from a glass ampoule and are pointless…
Coming back to: What published stability data actually covers, and what it does not Replied, post #147 · Practice › Storage & stability · 22 Sep 2025 · 0 likes Thank you for the correction. I would rather find out here than later.
Aggregated purity results across four services, with caveats — a second dataset Replied, post #135 · Data & Tools › Datasets · 11 Sep 2025 · 0 likes I read post #133 twice before replying, because I had assumed the opposite. Independent test results are the most valuable data this community collects, and they are…
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #13 · Analytics › Method validation · 24 Aug 2025 · 26 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. The…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #24 · Evidence › Journal club · 12 Aug 2025 · 27 likes Where I part company with post #20, and it is a narrow parting. The most common failure mode is spending fifty minutes on the effect size and ten on the population.…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #39 · Documentation › Doc review · 11 Aug 2025 · 3 likes This settles it for me, at least until somebody posts a reason it should not.
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #111 · Compounds › Semaglutide · 9 Aug 2025 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
Foaming during reconstitution and whether it matters Replied, post #20 · Practice › Reconstitution · 19 Jul 2025 · 11 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2025 · 9 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #7 · marked as the solution · Start Here › Welcome · 28 Jun 2025 · 7 likes Nobody is going to check your credentials and nobody is going to ask. What gets asked for is the basis of a claim, which is a different thing and applies equally to…
Coming back to: Official shortage notices and what they authorise Replied, post #29 · Access › Shortages · 14 Jun 2025 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
Sodium, potassium and magnesium when intake drops Replied, post #13 · Nutrition & Training › Hydration & electrolytes · 11 Jun 2025 · 0 likes I would put moderate confidence on the mainstream reading of sodium and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Appeal templates and why they are deliberately unemotional Replied, post #3 · Access › Insurance & coverage · 26 May 2025 · 8 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept. One more caveat and then I will stop qualifying: the sample…
Pregnancy as an absolute contraindication Replied, post #51 · Safety › Contraindications · 18 May 2025 · 0 likes Marking my place. If it changes for me I will come back and say so.
Validating a calculator against hand arithmetic — what changed since Replied, post #57 · Data & Tools › Calculators · 8 May 2025 · 4 likes Worth separating two things that post #54 runs together. Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed…
[2026 update] US compounding rules and how they changed Replied, post #9 · Regional › North America · 20 Apr 2025 · 29 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Counter-ion content and its effect on measured mass Replied, post #17 · Analytics › Mass spectrometry · 14 Apr 2025 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
Retatrutide dose escalation in the published trials Replied, post #92 · Compounds › Retatrutide · 5 Apr 2025 · 26 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #16 · Practice › Administration · 3 Apr 2025 · 24 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
Counter-ion form: the field almost nobody reports — one year on Replied, post #124 · Analytics › COA interpretation · 25 Mar 2025 · 27 likes A note on scope: what I am saying about Counter-ion form applies to the case in the first post and I would not extend it further without checking.
Revisiting: Filter needles: when they help and what they cost you Replied, post #7 · Devices › Syringes & needles · 20 Mar 2025 · 7 likes Saving this. It is the version I will quote when the question comes round again.
One lot is one lot: when a report becomes a pattern — the long version Replied, post #141 · Sourcing › Vendor reports · 19 Mar 2025 · 2 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #20 · Compounds › Retatrutide · 1 Mar 2025 · 22 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #24 · Practice › Reconstitution · 1 Mar 2025 · 9 likes I had written a reply contradicting post #22 and deleted it. Here is what survived. Swirling versus inverting versus leaving it alone: the vial can be gently warmed…
Follow-up: Attributing a new peak: degradation product or excipient? Replied, post #4 · Analytics › Impurities & related substances · 14 Feb 2025 · 0 likes The confident answers on Attributing a new peak and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #8 · Compounds › Semaglutide · 10 Feb 2025 · 2 likes Worth separating two things that post #4 runs together. STEP 1 and STEP 4 are two different questions. The first asks what happens when treatment is added; the second…
Reading a supplementary appendix and finding the interesting part Replied, post #81 · Evidence › Trials · 31 Jan 2025 · 0 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
Scheduled maintenance and what will be unavailable Replied, post #27 · Meta › Announcements · 28 Jan 2025 · 3 likes I read post #25 twice before replying, because I had assumed the opposite. One question about the transition rather than the policy: what happens to topics that are in…
Escalating every six weeks instead of four: what I observed over eight months Replied, post #32 · Practice › Dosing & titration · 23 Jan 2025 · 3 likes Everything in post #31 holds. The case it does not cover is the one I have. An observation about escalating every six weeks instead that I cannot explain and am posting…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #18 · Practice › Reconstitution · 23 Jan 2025 · 7 likes Adding the measurement that post #16 says would settle it. Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that…
Isotonicity and what happens when you get it wrong Replied, post #27 · Pharmacology › Formulation chemistry · 13 Jan 2025 · 1 like The difference between a formulated pharmaceutical product and a lyophilised research powder is most of the engineering, and almost none of it is visible in a purity…
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #35 · Compounds › Oral incretins · 9 Jan 2025 · 14 likes Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is made, stored and analysed. Comparing it to oral semaglutide as…
Recovery when intake is low: what to cut first Replied, post #9 · Nutrition & Training › Resistance training · 9 Jan 2025 · 0 likes Deload weeks matter more during a deficit than at maintenance because recovery is the limiting factor.
Fixed versus detachable needles: the trade-offs Replied, post #99 · Devices › Syringes & needles · 8 Jan 2025 · 9 likes On post #98 — agreed on the reasoning, with one qualification. U-100 means the barrel is graduated for a solution containing one hundred units of insulin per…
Coming back to: When to suspect the method rather than the sample Replied, post #98 · Analytics › Method validation · 19 Dec 2024 · 11 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
Body image changing more slowly than the body Replied, post #25 · Wellbeing › Mental health · 13 Dec 2024 · 0 likes Nothing to add, except that this is the answer I would give if asked.
EMA product information as a primary source — does this still hold? Replied, post #145 · Regional › European Union · 19 Nov 2024 · 22 likes Marking my uncertainty on EMA product information explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
Oxidation and deamidation mass shifts, tabulated Replied, post #5 · Analytics › Mass spectrometry · 10 Nov 2024 · 2 likes Adding the measurement that post #4 says would settle it. Since oxidation and deamidation mass shifts keeps coming up, it should probably be a maintained page rather…
Second pass at: Reimbursement variation across member states Replied, post #22 · Regional › European Union · 21 Oct 2024 · 29 likes Shortage notifications are published both centrally and nationally and the two do not always agree, usually because they are describing different things.
US compounding rules and how they changed Replied, post #7 · Regional › North America · 30 Sep 2024 · 32 likes I read post #3 twice before replying, because I had assumed the opposite. Nothing in this subcategory is medical or legal advice, and the clinicians posting here say so…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #40 · Analytics › COA interpretation · 29 Aug 2024 · 27 likes A certificate is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is not nothing.
Circumference measurements as a poor man's composition estimate Replied, post #81 · Outcomes › Body composition · 19 Aug 2024 · 4 likes Post #80 answers the question as asked. The question underneath it is different. Lean mass in these measurements includes water, so a change in hydration appears as a…
Circumference measurements as a poor man's composition estimate Replied, post #62 · Outcomes › Body composition · 12 Aug 2024 · 19 likes Post #61 put the caveat in the right place and I want to underline it. The most useful thing anyone has posted about circumference measurements in this category was a…
Guidelines revision: what changed and why Replied, post #9 · Meta › Announcements · 24 Jul 2024 · 13 likes Post #5 put the caveat in the right place and I want to underline it. Thank you for announcing it in advance rather than after. The number of places that do the reverse…